I 

117TH CONGRESS 

1ST SESSION H. R. 107 

To provide funds to the Centers for Medicare & Medicaid Services to provide 

grants to entities to establish lung cancer screening registries approved 

by the Centers for Medicare & Medicaid Services for submission of 

certain data required for reimbursement under the Medicare program 

for certain screening services, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 4, 2021 

Mr. HIGGINS of New York introduced the following bill; which was referred 

to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined 

by the Speaker, in each case for consideration of such provisions as fall 

within the jurisdiction of the committee concerned 

A BILL 

To provide funds to the Centers for Medicare & Medicaid 

Services to provide grants to entities to establish lung 

cancer screening registries approved by the Centers for 

Medicare & Medicaid Services for submission of certain 

data required for reimbursement under the Medicare program for certain screening services, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•HR 107 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Lung Cancer Screen3 ing Registry and Quality Improvement Act of 2021.’’ 

4 SEC. 2. GRANTS TO ESTABLISH LUNG CANCER SCREENING 

5 REGISTRIES APPROVED BY THE CENTERS 

6 FOR MEDICARE & MEDICAID SERVICES FOR 

7 SUBMISSION OF CERTAIN DATA REQUIRED 

8 FOR REIMBURSEMENT UNDER THE MEDI9 CARE PROGRAM FOR CERTAIN SCREENING 

10 SERVICES. 

11 (a) GRANTS.—There is appropriated to the Centers 

12 for Medicare & Medicaid Services, out of any moneys in 

13 the Treasury not otherwise appropriated, $2,000,000 for 

14 each of fiscal years 2022 through 2026 to make grants 

15 to entities to establish and carry out registries that are 

16 approved by the Centers for Medicare & Medicaid Services 

17 as meeting the requirements described in the Final Na18 tional Coverage Determination on Screening for Lung 

19 Cancer with Low Dose Computed Tomography published 

20 on February 5, 2015. 

21 (b) LIMITATION.—As a condition of receiving a grant 

22 pursuant to subsection (a), with respect to a registry de23 scribed in such subsection, an entity may not charge any 

24 fee for access to such registry. 


pbinns on DSKJLVW7X2PROD with BILLS
3 

•HR 107 IH

1 SEC. 3. ENCOURAGING DATA INTEROPERABILITY AMONG 

2 LUNG CANCER SCREENING REGISTRIES. 

3 The Secretary of Health and Human Services shall 

4 take such actions as may be necessary to ensure data 

5 interoperability between all registries described in section 

6 1(a) (including such registries established using funds pro7 vided under such section, interoperability between all 

8 CMS-approved lung cancer screening registries), including 

9 by— 

10 (1) requiring interoperability as a condition of 

11 receiving any Federal funding for such a registry; 

12 and 

13 (2) revoking any such funding for such a reg14 istry if the registry is not interoperable with other 

15 such registries. 

16 SEC. 4. GRANTS FOR THE DEVELOPMENT OF LUNG CANCER 

17 SCREENING, DETECTION, AND PREVENTION 

18 QUALITY MEASURES. 

19 (a) IN GENERAL.—Subject to subsection (c), the Sec20 retary of Health and Human Services shall award com21 petitive grants to organizations with quality measure de22 velopment expertise to develop, using data contained in 

23 registries described in section 1(a) (including such a reg24 istry established using funds provided under such section), 

25 quality and efficiency measures described in subsection (b) 

26 for review and potential endorsement by a consensusVerDate Sep 11 2014 06:52 Feb 02, 2021 Jkt 019200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H107.IH H107

pbinns on DSKJLVW7X2PROD with BILLS
4 

•HR 107 IH

1 based entity with a contract in effect under section 1890 

2 of the Social Security Act (42 U.S.C. 1395aaa) for uses 

3 including as described in subsection (b)(7)(B) of such sec4 tion. 

5 (b) QUALITY AND EFFICIENCY MEASURES DE6 SCRIBED.—For purposes of subsection (a), quality and ef7 ficiency measures described in this subsection are quality 

8 and efficiency measures to improve health care efficiency 

9 and outcomes with respect to lung cancer screening prac10 tices, early detection of lung cancer, and lung cancer pre11 vention. 

12 (c) AUTHORIZATION OF APPROPRIATIONS.—There is 

13 authorized to be appropriated to carry out subsection (a) 

14 $1,000,000 for each of fiscal years 2022 through 2026. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS